# Beijing Zeno Technology Development Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beijing-zeno-technology-development-co

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.zenobiotech.cn
- Total disclosed funding: $1.6M
- Latest round: Angel (Mar 14, 2022)
- Investors on record: 2

## About

Founded in 2020 and based in Beijing, China, Zeno Biotech is headquartered in Beijing with R&D and production facilities in Suzhou and Dongying. The company specializing in synthetic biology-based production of high-value natural products such as microbial pigments and functional ingredients. It has received recognition such as “National High-Tech Enterprise” and “Zhongguancun High-Tech Enterprise” and was awarded the “Kun Cheng Talent” distinction by Suzhou authorities. In August 2025, Zeno Biotech closed a round of pre-series A funding.

The company focuses on the development and production of functional ingredients such as 2’-Fucosyllactose (2’-FL), microbial pigments, salidroside, sialic acid, and other bioactive compounds. The company has independently developed proprietary engineered microbial strains and holds multiple patents. It provides large-scale fermentation services, with key applications in infant formula, digestive health, personal care and natural dyes for textile and food industries.

The company generates revenue by commercializing bio-manufactured functional ingredients and microbial products.

Zeno Biotech plans to expand its production capacity, accelerate R&D pipelines and strengthen its commercialization capabilities. The company aims to scale current production to kiloton levels and broaden global market access in synthetic biology-based health and nutrition applications.

## Funding rounds

- Angel, Mar 14, 2022, $1.6M — CITIC Capital Holdings, Next Capital

## Investors

- CITIC Capital Holdings (https://capitalatlas.ai/funds/citic-capital-holdings) — Angel
- Next Capital — Angel